You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
AstraZeneca
McKesson
Express Scripts
Colorcon

Last Updated: May 10, 2021

DrugPatentWatch Database Preview

Litigation Details for KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC (D.N.J. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC (D.N.J. 2018)

Docket   Get Started for $10 Date Filed 2018-11-08
Court District Court, D. New Jersey Date Terminated 2019-06-14
Cause 35:271 Patent Infringement Assigned To Brian R. Martinotti
Jury Demand Plaintiff Referred To Tonianne J. Bongiovanni
Parties ALLERGAN SALES, LLC
Patents 7,622,130; 7,754,230; 8,101,593; 8,242,294; 8,298,556; 8,367,649; 8,461,140; 8,546,367; 8,653,058; 8,846,066; 8,883,770; 9,522,155; 9,636,349; 9,949,986
Attorneys AMIT SINGHAI
Firms Budd Larner, PC
Link to Docket External link to docket
Small Molecule Drugs cited in KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC
The small molecule drug covered by the patents cited in this case is   Get Started for $10 .
Biologic Drugs cited in KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC

The biologic drugs covered by the patents cited in this case are   Get Started for $10 ,   Get Started for $10 ,   Get Started for $10 ,   Get Started for $10 , and   Get Started for $10 .

Details for KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-11-08 1 identifies the following patents as covering Kybella®: U.S. Patent Nos. 7,622,130; 7,754,230; 8,101,593;…four other patents listed in the Orange Book related to Kybella®: U.S. Patent Nos. 7,622,130; 7,754,230… III certification with regard to U.S. Patent Nos. 7,622,130; 7,754,230; 8,298,556 and 8,846,066. …27 PageID: 2 Patent Nos. 8,101,593 (the “’593 patent”); 8,367,649 (the “’649 patent”); and 8,653,058…1. This is an action for patent infringement arising under the patent laws of the United States, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Medtronic
Harvard Business School
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.